Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients

BACKGROUND: Combination therapy with ezetimibe/simvastatin (E/S) and extended‐release niacin (N) has been reported to be safe and efficacious in concomitantly reducing low‐density lipoprotein cholesterol and increasing high‐density lipoprotein cholesterol in hyperlipidemic patients at high risk for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Le, Ngoc‐Anh, Jin, Ran, Tomassini, Joanne E., Tershakovec, Andrew M., Neff, David R., Wilson, Peter W.F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828803/
https://ncbi.nlm.nih.gov/pubmed/23926117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000037
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares